Discover the detailed record of transactions filed by Sebastian Hansson, Autre Membre du Conseil. Director active across 2 companies, notably Alzinova AB. Cumulatively, 4 disclosures have been recorded. Activity tracked since 2 April 2025. The latest transaction was disclosed on 6 May 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
10,000 shares@ €0.19060.0028% mcap74.9% of flowAktieFI:A003N143-1
Ideal exit: 28 Dec 2025 (T+270)
4 of 4 declarations
About Sebastian Hansson
Sebastian Hansson is a board member of Alzinova AB, a company specializing in the development of treatments for neurodegenerative diseases. In his role, he participates in the governance of the company and strategic decision-making. Sebastian brings valuable expertise in the biotechnology field, contributing to innovation and research at Alzinova. His commitment to excellence is an asset to the company.